Tolerability and efficacy of classical CMF(cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamide (IVC) in early stage breast cancer: a non-radnomised comparison of patients treated in the NEAT trial

Daniel Rea, Louise Hiller, HM Earl, JA Dunn, Sarah Bathers, David Spooner, Robert Grieve, RK Agrawal, Christopher Poole, NEAT Investigators

Research output: Contribution to journalArticle

Original languageEnglish
Article numbersuppl 595
Number of pages1
JournalProceedings of the American Society of Clinical Oncology
Publication statusPublished - 1 Jan 2004

Cite this